Replies to post #108639 on Biotech Values

[ciotera]

Ribavarin comes at the cost of CNS side-effects, so if SVR is already high, I'd think twice before adding it for an extra 5%.

Especially in post-telaprevir world, I think efficacy is not going to be as strong of a differentiator as other parameters.